News
2021.09.03

Zenshine Announced Dr. Xiaoli Qin as Chief Science Officer

View More
2021.07.05

Zenshine Receives US FDA IND Approval to Initiate Clinical Trial for ZX-4081

View More
2021.06.06

Zenshine Pharma Announces Completion of Series A+ Financing

View More
2021.04.15

Zenshine Pharma releases four new research results at the AACR 2021

View More
2021.02.23

The first patient received ZX-101A treatment in the United States

View More
2021.02.23

Zenshine Pharma will present important research results at the AACR 2021

View More
2021.02.05

Zenshine Pharma Raised $15 Million in Series A Financing

View More
2020.06.17

Zenshine’s first IND approval by the US FDA

View More